000 | 01821 a2200457 4500 | ||
---|---|---|---|
005 | 20250517114235.0 | ||
264 | 0 | _c20171031 | |
008 | 201710s 0 0 eng d | ||
022 | _a1463-1326 | ||
024 | 7 |
_a10.1111/dom.12731 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShirakawa, J | |
245 | 0 | 0 |
_aNovel factors modulating human β-cell proliferation. _h[electronic resource] |
260 |
_bDiabetes, obesity & metabolism _c09 2016 |
||
300 |
_a71-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdaptor Proteins, Signal Transducing _xantagonists & inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aDenosumab _xpharmacology |
650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 beta _xantagonists & inhibitors |
650 | 0 | 4 |
_aHarmine _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aI-kappa B Kinase _xantagonists & inhibitors |
650 | 0 | 4 |
_aInsulin-Secreting Cells _xcytology |
650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aOsteoprotegerin _xpharmacology |
650 | 0 | 4 |
_aPhenylurea Compounds _xpharmacology |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aRNA-Binding Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptor Activator of Nuclear Factor-kappa B _xantagonists & inhibitors |
650 | 0 | 4 |
_aSerine Proteinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aSerpins _xpharmacology |
650 | 0 | 4 |
_aTryptamines _xpharmacology |
650 | 0 | 4 | _aDyrk Kinases |
700 | 1 | _aKulkarni, R N | |
773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 18 Suppl 1 _gp. 71-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/dom.12731 _zAvailable from publisher's website |
999 |
_c26407377 _d26407377 |